The US Centers for Medicare and Medicaid Services will hold a town hall in early December to discuss FY 2020 applications for new add-on payments for technologies under the hospital inpatient prospective payment system.

US FDA hasn't posted a device-related close-out letter online in five months. Agency spokeswoman Deborah Kotz says firms were "issued" close-outs over the past six months – they just haven't been posted online yet. But a firm being "issued" a close-out letter isn't the same as having FDA publicly announce it online for the world to see – which, one could argue, is the whole reason behind the close-out program in the first place. See what else Kotz said here.

Medtech and political experts agree the Democrats will likely take control of the US House after the upcoming election but, if they do, very little legislation will be able to get passed because of GOP dominance in the Senate and White House. But there will be plenty of oversight hearings.

There is a global lack of readiness to comply with EU's Medical Device and IVD Regulations, according to survey results, adding weight to the EU medtech industry's message that a delay is needed.

The Utah Supreme Court is reviewing a case that could give device companies some protection from product liability suits. Industry heavyweights including AdvaMed and the Washington Legal Foundation have weighed in by filing briefs supporting defendant Wright Medical.

Medical device manufacturers under the dark cloud of a US FDA warning letter work hard to close them out, and, importantly, receive a close-out letter from the agency that is posted online for everyone to see. Yet FDA hasn't publicly released such a missive to device companies since May – the longest gap since the close-out program began in 2010. FDA says it's aware of the problem.

Medical device manufacturers under the dark cloud of a US FDA warning letter work hard to close them out, and, importantly, receive a close-out letter from the agency that is posted online for everyone to see. Yet FDA hasn't publicly released such a missive to device companies since May – the longest gap since the close-out program began in 2010. FDA says it's aware of the problem.

Medtech Insight’s Shawn M. Schmitt talks about Part 4 of “Medtech’s Next Top Maturity Model,” his feature series on the appraisal of device-makers’ manufacturing capability and maturity. This episode focuses on appraisers affiliated with Pittsburgh's CMMI Institute and describes the hurdles they must clear to be part of a US FDA pilot program that uses an industry-tailored version of the Capability Maturity Model Integration (CMMI) framework.

From training classes to onsite observations, two lead appraisers affiliated with Pittsburgh's CMMI Institute describe the high hurdles they jumped to be part of a flourishing US FDA pilot program that aims to elevate product, manufacturing and process quality at device firms. The pilot uses an industry-tailored version of the tried-and-true Capability Maturity Model Integration (CMMI) framework that's been around for decades. Beth Layman, an appraiser who has assessed more than a hundred companies in a variety of industries, says appraisers can't just be book-smart – rather, they must also possess a select set of personal skills, including flexibility and open-mindedness. Her fellow appraiser Thayne Hill, who "was there in the early days" of the Capability Maturity Model, says device-makers are often leery of appraisers because of past negative interactions with regulators, which can make his job challenging.

The fourth of a multi-part Medtech Insight feature series on the appraisal of manufacturing capability and maturity, and what it means for the medical device industry.

Recent moves up the ladder: new COOs at Beckton Dickinson and Abbott, a chief technology officer at LuxCath, and a chief growth officer at Varian Medical. In addition, the chairman of BTG announced his decision to depart at the end of the year.

The company's device business chief is expanding his portfolio as Abbott's new president and chief operating officer, leading to some speculation that he is being positioned to be the next CEO.

Myriad Genetics, Inc. and Pfizer Inc. signed an agreement to promote Myriad's BRACAnalysis CDx test, currently under US FDA review, as a companion diagnostic for Pfizer's investigational breast cancer drug, talazoparib.

This edition of Medtech Money Flow rounds up the M&A and venture financing deals, as recorded in our M&A and VC Deal Trackers, between Oct. 1 and Oct. 7. 

Orthopedics firm Corin is targeting the competitive Australian market with its latest acquisition. The Cirencester, UK-based company announced a deal to acquire Global Orthopaedics Technology (GOT), a leading Australian orthopedics group.

The US International Trade Commission has agreed to investigate ResMed’s complaint that a New Zealand company and its American subsidiaries are illegally importing and selling sleep masks that violate ResMed patents.

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. Among the four added this week, Tandem Diabetes and Medtronic both gained integrated insulin pump system approvals in Canada.

Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements made Oct. 8 through Oct. 14, including trial announcements from Abbott Laboratories, Medtronic, Edwards Lifesciences, Carag AG, DJO Global, RTI Surgical, and Terumo.

Mobile apps made major headway into the world of US FDA regulation in the third quarter, with de novo go-aheads for two Apple Watch heart-rhythm apps and the first FDA approval of a smartphone app to support contraception. Meanwhile, original PMA-approval volumes continue to lag in 2018. Here's an infographic to spotlight US device approval trends during the third quarter, July through September.

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. A smart contact lens, self-fitting hearing aid and laser eye surgery device are among the new additions to the tracker.

Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements made Oct. 1 through Oct. 7, including trial announcements from Apollo Endosurgery, SPR Therapeutics, Endologix, and EPIX Therapeutics.

Results Recap is Medtech Insight's exclusive summary of clinical trial results that have been announced or published in the past week, based on information collected by Meddevicetracker. This week's edition covers the week of Sept. 28 - Oct. 4, including trial announcements from Medtronic, Neovasc, OptiMesh, and PHC Holdings.